Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: May 26, 2019
Open Peer Review Period: May 29, 2019 - Jul 19, 2019
Date Accepted: May 14, 2020
Date Submitted to PubMed: Jun 10, 2020
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Dose-Response Relationship of a Web-Based Tailored Intervention Promoting Human Papillomavirus Vaccination: Process Evaluation of a Randomized Controlled Trial

Pot M, Paulussen TGWM, Ruiter RAC, Mollema L, Hofstra M, Van Keulen HM

Dose-Response Relationship of a Web-Based Tailored Intervention Promoting Human Papillomavirus Vaccination: Process Evaluation of a Randomized Controlled Trial

J Med Internet Res 2020;22(7):e14822

DOI: 10.2196/14822

PMID: 32520718

PMCID: 7395256

Dose-response relationship of a Web-based Tailored Intervention Promoting HPV Vaccination: Process Evaluation

  • Mirjam Pot; 
  • Theo Gerardus Wilhelmus Maria Paulussen; 
  • Robert Antonie Christiaan Ruiter; 
  • Liesbeth Mollema; 
  • Miranda Hofstra; 
  • Hilde Marijke Van Keulen

ABSTRACT

Background:

In the Netherlands, HPV vaccination uptake remains low. To improve informed decision making (IDM) and HPV vaccination acceptability, we systematically developed an interactive, Web-based tailored intervention for mothers of Dutch girls to-be-invited.

Objective:

The aim of this study is to provide insight into the intervention’s working mechanisms by evaluating (1) program use, (2) program acceptability, and (3) the relationship of program use with (a) program acceptability, and (b) intervention effects (i.e., dose-response).

Methods:

Only mothers from the intervention arm of a randomized controlled study (RCT) that assessed the effectiveness of the Web-based, tailored intervention were included. They were invited to visit the Web-based intervention between baseline (January 2015, just before access to the intervention) and follow-up (March 2015, prior to the first HPV vaccination). Indicators for program use were time of website use (i.e., duration of intervention exposure) and completeness (i.e., the proportion of all available webpages visited). HPV vaccination uptake registered by Praeventis was used as the primary outcome. Secondary outcomes were informed decision-making (IDM), decisional conflict, and social psychological determinants of HPV vaccination uptake.

Results:

From the 3995 invited mothers, 2509 mothers (62.80%) logged in. Of these, 2239 mothers (89.24%) visited at least one page of the intervention components. On average, mothers spent 21.39 minutes on the website (SD = 12.41 minutes) and completed 50.04% (SD = 26.18%) of the website. Participants rated the website with a 7.64 on a 10-point scale (SD = 1.39). Program acceptability was significantly associated with completeness (β = 4.36, P < .001), but not with time of website use (β = -.07, P =.77). Intention-to-treat analysis (N = 3,995) showed a significant positive effect of completeness on all outcome measures (P’s <.003; Bonferroni corrected alpha=.05/15 factors), including on HPV vaccination uptake. Time of website use had a significant positive effect on all outcomes (P’s <.003), except for uptake (P = .195), risk perception when not vaccinated (P = .144), subjective norms (P = .032), and habit (P = .013).

Conclusions:

Program use and acceptability of the intervention was adequate. Completeness was positively associated with acceptability. Furthermore, positive effects (i.e., dose-response effects) were found of completeness and time of website use on the mothers IDM, decisional conflict, and almost all of the social-psychological determinants of HPV vaccination acceptability. In addition, the extent to which mothers completed the intervention had a positive impact on their daughters’ vaccination uptake. This indicates that the Web-based, tailored intervention fits well with the mothers’ needs, and that completeness of use is essential for improving HPV vaccination uptake, acceptability, and IDM. Program use should therefore be promoted. Clinical Trial: Trial Registration: Trialregister.nl NTR4795; https://www.trialregister.nl/trial/4795


 Citation

Please cite as:

Pot M, Paulussen TGWM, Ruiter RAC, Mollema L, Hofstra M, Van Keulen HM

Dose-Response Relationship of a Web-Based Tailored Intervention Promoting Human Papillomavirus Vaccination: Process Evaluation of a Randomized Controlled Trial

J Med Internet Res 2020;22(7):e14822

DOI: 10.2196/14822

PMID: 32520718

PMCID: 7395256

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.